Envestnet Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.6M | Buy |
136,798
+34,445
| +34% | +$4.66M | 0.01% | 1392 |
|
|
2026
Q1 | $13.1M | Buy |
102,353
+21,601
| +27% | +$2.7M | ﹤0.01% | 1640 |
|
|
2025
Q4 | $9.85M | Buy |
80,752
+24,141
| +43% | +$2.77M | ﹤0.01% | 1700 |
|
|
2025
Q3 | $5.67M | Sell |
56,611
-5,743
| -9% | -$517K | ﹤0.01% | 2152 |
|
|
2025
Q2 | $5.17M | Sell |
62,354
-56,410
| -47% | -$4.5M | ﹤0.01% | 2180 |
|
|
2025
Q1 | $9.63M | Sell |
118,764
-16,015
| -12% | -$1.43M | ﹤0.01% | 1689 |
|
|
2024
Q4 | $12.1M | Sell |
134,779
-65,481
| -33% | -$6.34M | ﹤0.01% | 1507 |
|
|
2024
Q3 | $19.8M | Buy |
200,260
+13,860
| +7% | +$1.36M | 0.01% | 1189 |
|
|
2024
Q2 | $17.3M | Buy |
186,400
+20,685
| +12% | +$1.85M | 0.01% | 1215 |
|
|
2024
Q1 | $15.7M | Buy |
165,715
+30,059
| +22% | +$2.79M | 0.01% | 1240 |
|
|
2023
Q4 | $12.1M | Buy |
135,656
+9,655
| +8% | +$717K | 0.01% | 1315 |
|
|
2023
Q3 | $9.2M | Buy |
126,001
+6,884
| +6% | +$550K | ﹤0.01% | 1424 |
|
|
2023
Q2 | $9.91M | Sell |
119,117
-357
| -0.3% | -$29.9K | ﹤0.01% | 1312 |
|
|
2023
Q1 | $9.11M | Buy |
119,474
+13,550
| +13% | +$1.12M | ﹤0.01% | 1288 |
|
|
2022
Q4 | $8.79M | Buy |
105,924
+26,575
| +33% | +$2.15M | ﹤0.01% | 1268 |
|
|
2022
Q3 | $6.29M | Sell |
79,349
-17,383
| -18% | -$1.47M | ﹤0.01% | 1398 |
|
|
2022
Q2 | $7.18M | Buy |
96,732
+26,958
| +39% | +$2.02M | ﹤0.01% | 1319 |
|
|
2022
Q1 | $6.27M | Sell |
69,774
-2,855
| -4% | -$264K | ﹤0.01% | 1466 |
|
|
2021
Q4 | $8.13M | Buy |
72,629
+27,084
| +59% | +$3.27M | ﹤0.01% | 1302 |
|
|
2021
Q3 | $5.72M | Sell |
45,545
-7,340
| -14% | -$945K | ﹤0.01% | 1452 |
|
|
2021
Q2 | $7.16M | Buy |
52,885
+3,522
| +7% | +$463K | ﹤0.01% | 1308 |
|
|
2021
Q1 | $6.7M | Buy |
49,363
+11,868
| +32% | +$1.78M | ﹤0.01% | 1264 |
|
|
2020
Q4 | $5.28M | Buy |
37,495
+3,643
| +11% | +$467K | ﹤0.01% | 1256 |
|
|
2020
Q3 | $3.77M | Buy |
33,852
+13,287
| +65% | +$1.49M | ﹤0.01% | 1302 |
|
|
2020
Q2 | $2.3M | Sell |
20,565
-3,884
| -16% | -$383K | ﹤0.01% | 1491 |
|
|
2020
Q1 | $1.89M | Sell |
24,449
-1,273
| -5% | -$113K | ﹤0.01% | 1450 |
|
|
2019
Q4 | $2.45M | Buy |
25,722
+791
| +3% | +$68.4K | ﹤0.01% | 1495 |
|
|
2019
Q3 | $1.9M | Sell |
24,931
-474
| -2% | -$39.4K | ﹤0.01% | 1568 |
|
|
2019
Q2 | $2.23M | Buy |
25,405
+3,042
| +14% | +$259K | ﹤0.01% | 1498 |
|
|
2019
Q1 | $2.02M | Buy |
22,363
+2,487
| +13% | +$212K | ﹤0.01% | 1470 |
|
|
2018
Q4 | $1.43M | Buy |
+19,876
| New | +$1.6M | ﹤0.01% | 1529 |
|
|
2018
Q3 | – | Sell |
-50,389
| Closed | -$4.8M | – | 2655 |
|
|
2018
Q2 | $4.8M | Buy |
50,389
+44,221
| +717% | +$4.06M | 0.01% | 502 |
|
|
2018
Q1 | $532K | Sell |
6,168
-49,371
| -89% | -$4.51M | ﹤0.01% | 1185 |
|
|
2017
Q4 | $4.71M | Buy |
55,539
+48,922
| +739% | +$4.1M | 0.01% | 623 |
|
|
2017
Q3 | $572K | Buy |
6,617
+2,257
| +52% | +$181K | ﹤0.01% | 1403 |
|
|
2017
Q2 | $335K | Sell |
4,360
-2,846
| -39% | -$202K | ﹤0.01% | 1678 |
|
|
2017
Q1 | $501K | Sell |
7,206
-1,950
| -21% | -$131K | ﹤0.01% | 1521 |
|
|
2016
Q4 | $541K | Buy |
9,156
+1,982
| +28% | +$122K | ﹤0.01% | 1464 |
|
|
2016
Q3 | $476K | Sell |
7,174
-8,278
| -54% | -$512K | ﹤0.01% | 1596 |
|
|
2016
Q2 | $836K | Buy |
15,452
+130
| +0.8% | +$7.12K | ﹤0.01% | 1411 |
|
|
2016
Q1 | $792K | Sell |
15,322
-544
| -3% | -$28.3K | ﹤0.01% | 1430 |
|
|
2015
Q4 | $1.11M | Buy |
15,866
+3,041
| +24% | +$207K | 0.01% | 1228 |
|
|
2015
Q3 | $798K | Sell |
12,825
-113,718
| -90% | -$8.96M | ﹤0.01% | 1383 |
|
|
2015
Q2 | $10.6M | Buy |
126,543
+99,603
| +370% | +$7.75M | 0.05% | 353 |
|
|
2015
Q1 | $2.02M | Buy |
26,940
+25,503
| +1,775% | +$1.78M | 0.01% | 962 |
|
|
2014
Q4 | $89K | Buy |
1,437
+156
| +12% | +$8.89K | ﹤0.01% | 1215 |
|
|
2014
Q3 | $67K | Buy |
1,281
+396
| +45% | +$20.2K | ﹤0.01% | 1417 |
|
|
2014
Q2 | $45K | Buy |
885
+684
| +340% | +$30.8K | ﹤0.01% | 1478 |
|
|
2014
Q1 | $10K | Buy |
201
+177
| +738% | +$9.06K | ﹤0.01% | 1893 |
|
|
2013
Q4 | $1K | Sell |
24
-4,482
| -99% | -$186K | ﹤0.01% | 2377 |
|
|
2013
Q3 | $194K | Sell |
4,506
-1,767
| -28% | -$71.6K | ﹤0.01% | 802 |
|
|
2013
Q2 | $218K | Buy |
+6,273
| New | +$220K | ﹤0.01% | 785 |
|
Other funds holding XBI
JFG
Envestnet Asset Management's XBI Position: Q2 2026 in Review
Envestnet Asset Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 34% in Q2 2026, buying an estimated $4.66M and bringing the position to 136,798 shares worth $21.6M. The position accounts for 0.01% of the portfolio, ranked #1392.
Envestnet Asset Management first reported a position in XBI in Q2 2013 and has held it in 52 quarters since. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Envestnet Asset Management held 136,798 shares of State Street SPDR S&P Biotech ETF worth $21.6M as of Q2 2026.
- Envestnet Asset Management bought 34,445 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $4.66M.
- State Street SPDR S&P Biotech ETF made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1392 holding.
- Envestnet Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 52 quarters since.
- 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.